Trials / Completed
CompletedNCT04340219
Oncology-patient-reported Anxiety, Mood, and QoL During the COVID-19 Pandemic
A Prospective Cohort Study Investigating Oncology-patient-reported Anxiety, Mood, and Quality of Life During the COVID-19 Pandemic (ONCOVID Trial)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 394 (actual)
- Sponsor
- University Hospital, Ghent · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
ONCOVID is a prospective cohort study investigating oncology-patient-reported anxiety, mood, and quality of life during the COVID-19 pandemic. Participants complete a survey consisting of sociodemographic information and self-administered questionnaires (COVID-19 Peritraumatic Distress Index, Depression Anxiety Stress Scale-21, and WHO Quality of Life-BREF). Data collection occurs at baseline and follow-up surveys are performed after 6, 12, and 24 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Survey administration | Covid-19 Peritraumatic Distress Index, Depression Anxiety Stress Scale-21, WHO Quality of Life-BREF |
Timeline
- Start date
- 2020-03-30
- Primary completion
- 2020-04-10
- Completion
- 2020-09-18
- First posted
- 2020-04-09
- Last updated
- 2020-09-25
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT04340219. Inclusion in this directory is not an endorsement.